论文部分内容阅读
近年来,国内外同种骨髓移植、胎肝移植治疗恶性血液病已有不少成功的报道,但由于需特殊设备、价格昂贵及移植免疫学问题至今尚未妥善解决而不能广泛应用。相比之下,造血细胞输注简单方便,适应证范围也广,且有一定疗效。尤其是人胎肝造血
In recent years, domestic and foreign allogeneic bone marrow transplantation, fetal liver transplantation for the treatment of hematological malignancies have been many successful reports, but due to the need for special equipment, expensive and immunological problems have not yet been properly solved and can not be widely used. In contrast, simple and convenient infusion of hematopoietic cells, indications are also wide range, and have a certain effect. Especially human fetal liver hematopoiesis